Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
429.86
+1.43 (0.33%)
Oct 16, 2026, 9:51 AM EDT - Market open
Elevance Health Stock Forecast
Stock Price Forecast
According to 22 analysts polled by S&P Global, Elevance Health stock has a consensus rating of "Buy" and an average price target of $451.71. The average 1-year stock price forecast is 5.08% higher than the current stock price, while the lowest is $393 (-8.57%) and the highest is $492 (+14.46%).
Price Target: $451.71 (+5.08%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Elevance Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 12 | 12 | 12 | 12 | 12 |
| Buy | 3 | 2 | 3 | 3 | 2 | 2 |
| Hold | 7 | 8 | 7 | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 22 | 22 | 22 | 22 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $455 → $460 | Buy | Reiterates | $455 → $460 | +7.01% | Oct 12, 2026 |
| Barclays | Barclays | Buy Maintains $457 → $469 | Buy | Maintains | $457 → $469 | +9.11% | Oct 7, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $424 | Hold | Maintains | $424 | -1.36% | Oct 7, 2026 |
| Bernstein | Bernstein | Buy Maintains $488 | Buy | Maintains | $488 | +13.53% | Oct 5, 2026 |
| UBS | UBS | Buy Maintains $460 | Buy | Maintains | $460 | +7.01% | Sep 18, 2026 |
Financial Forecast
Revenue This Year
196.44B
from 199.13B
Decreased by -1.35%
Revenue Next Year
200.24B
from 196.44B
Increased by 1.93%
EPS This Year
27.24
from 30.29
Decreased by -10.06%
EPS Next Year
29.60
from 27.24
Increased by 8.65%
EPS and Forward PE are based on non-GAAP adjusted numbers.